Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hong, 2014, Circulating MicroRNAs in gynecological malignancies: from detection to prediction, Exp Hematol Oncol, 3, 14, 10.1186/2162-3619-3-14
Shih Ie, 2004, Molecular genetic analysis of ovarian serous cystadenomas, Lab Invest, 84, 778, 10.1038/labinvest.3700103
Langdon, 2005, Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen, Endocr Relat Cancer, 12, 851, 10.1677/erc.1.01039
Cajander, 2001, Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors, Int J Oncol, 19, 31
Mylonas, 2010, Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary, Arch Gynecol Obstet, 281, 511, 10.1007/s00404-009-1185-y
Li, 2004, GW112, a novel antiapoptotic protein that promotes tumor growth, Cancer Res, 64, 2474, 10.1158/0008-5472.CAN-03-3443
Rodgers, 2002, Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development, Gene, 283, 83, 10.1016/S0378-1119(01)00763-6
Tenen, 2004, pDP4, a novel glycoprotein secreted by mature granulocytes, is regulated by transcription factor PU. 1, Blood, 103, 4294, 10.1182/blood-2003-08-2688
Anholt, 2000, Characterization and differential expression of a human gene family of olfactomedin-related proteins, Genet Res, 76, 41, 10.1017/S0016672300004584
Chen, 2011, Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers, Neoplasma, 58, 9, 10.4149/neo_2011_01_9
Rodgers, 2007, Expression of hGC-1 is correlated with differentiation of gastric carcinoma, Histopathology, 51, 157, 10.1111/j.1365-2559.2007.02763.x
Watanabe, 2007, Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells, Cancer Sci, 98, 334, 10.1111/j.1349-7006.2007.00397.x
Watanabe, 2007, Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis, Cancer Sci, 98, 315, 10.1111/j.1349-7006.2006.00383.x
Wang, 2011, OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer, J Cancer Res Clin Oncol, 137, 1713, 10.1007/s00432-011-1042-9
Rodgers, 2008, Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma, Clin Cancer Res, 14, 1041, 10.1158/1078-0432.CCR-07-4125
Rodgers, 2011, Olfactomedin 4 suppresses prostate cancer cell growth and metastasisnegative interaction with cathepsin D and SDF-1, Carcinogenesis, 32, 986, 10.1093/carcin/bgr065
Chen, 2011, Olfactomedin 4 is a marker for progression of cervical neoplasia, Int J Gynecol Cancer, 21, 367, 10.1097/IGC.0b013e31820866fe
Yu, 2014, Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma, J Cell Mol Med, 18, 863, 10.1111/jcmm.12232
Olson, 2010, Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486, Proc Natl Acad Sci U S A, 107, 4218, 10.1073/pnas.1000300107
Tan, 2011, Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer, Clin Cancer Res, 17, 2657, 10.1158/1078-0432.CCR-10-3152
Haier, 2009, Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas, Ann Surg Oncol, 16, 2339, 10.1245/s10434-009-0531-4
Litman, 2014, Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status, Cell Oncol (Dordr), 37, 215
Jiang, 2014, Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer, Oncogene, 33, 1181, 10.1038/onc.2013.42
Wang, 2015, MiR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10 and CITRON, Hepatol Res, 45, 1312, 10.1111/hepr.12500
Li, 2013, miR-486 sustains NF-kappaB activity by disrupting multiple NF-kappaB-negative feedback loops, Cell Res, 23, 274, 10.1038/cr.2012.174
Xing, 2014, Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer, Mol Cancer, 13, 240, 10.1186/1476-4598-13-240
Kuroda, 2012, TLS-CHOP represses miR-486 expression, inducing upregulation of a metastasis regulator PAI-1 in human myxoid liposarcoma, Biochem Biophys Res Commun, 427, 355, 10.1016/j.bbrc.2012.09.063
Ding, 2014, Estrogen combined with progesterone decreases cell proliferation and inhibits the expression of Bcl-2microRNA let-7a and miR-34b in ovarian cancer cells, Clin Transl Oncol, 16, 898, 10.1007/s12094-014-1166-x
Liu, 2014, microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor alpha-positive ovarian cancer cells, Mol Med Rep, 9, 1703, 10.3892/mmr.2014.2021
Hua, 2014, Estrogen stimulates the invasion of ovarian cancer cellsactivation of the PI3K/AKT pathway and regulation of its downstream targets Ecadherin and alphaactinin4, Mol Med Rep, 10, 2433, 10.3892/mmr.2014.2561